Literature DB >> 9362446

The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene.

R J Isfort1, D B Cody, C J Doersen, W G Richards, B K Yoder, J E Wilkinson, L D Kier, R L Jirtle, J S Isenberg, J E Klounig, R P Woychik.   

Abstract

The Tg737 gene was investigated for gross alterations in a series of rodent/human liver tumors and human tumorigenic cell lines. The Tg737 gene was found to be altered in approximately 40% of the rodent chemically-induced liver tumors, 40% of the human liver tumors, and in liver, kidney and pancreatic human tumor cell lines. Ectopic re-expression of the Tg737 gene in a Tg737 deleted mouse liver tumor cell line resulted in suppression of tumorigenic growth, without altering in vitro cell culture growth. Treatment of mice which are either homozygous normal or heterozygous deleted at the Tg737 locus with the carcinogen diethylnitrosamine resulted in an increase in preneoplastic foci formation in the Tg737 heterozygous deleted mice. Ectopic expression of the Tg737 gene results in multinucleated cells, loss of Tg737 gene expression results in the proliferation of liver stem cells (oval cells) without concomitant differentiation, and reexpression of the Tg737 gene reestablished responsiveness to external differentiation factors. We believe this is the first report demonstrating tumor suppression activity for a tetratricopeptide repeat gene family member and provides insights into the function of this family of genes in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362446     DOI: 10.1038/sj.onc.1201535

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  New frontiers: discovering cilia-independent functions of cilia proteins.

Authors:  Anastassiia Vertii; Alison Bright; Benedicte Delaval; Heidi Hehnly; Stephen Doxsey
Journal:  EMBO Rep       Date:  2015-09-09       Impact factor: 8.807

Review 2.  Liver cancer: the role of stem cells.

Authors:  M R Alison; M J Lovell
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

Review 3.  Liver stem cells: implications for hepatocarcinogenesis.

Authors:  Malcolm R Alison
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

4.  Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.

Authors:  Zhi Song; Ren Li; Nan You; Kaishan Tao; Kefeng Dou
Journal:  Mol Biol Rep       Date:  2010-03-19       Impact factor: 2.316

5.  Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia.

Authors:  E Scott Seeley; Catherine Carrière; Tobias Goetze; Daniel S Longnecker; Murray Korc
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

6.  MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.

Authors:  Ge Zhao; Ting Wang; Qi-Ke Huang; Meng Pu; Wei Sun; Zhuo-Chao Zhang; Rui Ling; Kai-Shan Tao
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

7.  HDAC6 inhibition restores ciliary expression and decreases tumor growth.

Authors:  Sergio A Gradilone; Brynn N Radtke; Pamela S Bogert; Bing Q Huang; Gabriella B Gajdos; Nicholas F LaRusso
Journal:  Cancer Res       Date:  2013-01-31       Impact factor: 12.701

Review 8.  Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors.

Authors:  Wei-Hui Liu; Nan You; Ning Zhang; Hong-Tao Yan; Tao Wang; Zhu Huang; Hong-Bao Liu; Li-Jun Tang
Journal:  Cell Oncol (Dordr)       Date:  2012-11-22       Impact factor: 6.730

9.  Tg737 signaling is required for hypoxia-enhanced invasion and migration of hepatoma cells.

Authors:  Nan You; Weihui Liu; Lijun Tang; Xiao Zhong; Ru Ji; Ning Zhang; Desheng Wang; Yong He; Kefeng Dou; Kaishan Tao
Journal:  J Exp Clin Cancer Res       Date:  2012-09-13

10.  Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma.

Authors:  Yi Huang; Jiaying Zheng; Dunyan Chen; Feng Li; Wenbing Wu; Xiaoli Huang; Yanan Wu; Yangyang Deng; Funan Qiu
Journal:  Oncotarget       Date:  2017-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.